Jasmine
Analyst
UBS
Equibles does not estimate personal net worth.
About Jasmine
Jasmine is recorded as Analyst at UBS. Jasmine has spoken on 2 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on August 4, 2025. The companies whose calls Jasmine spoke on are classified in the Healthcare sector.
Jasmine on recent calls
“So, what's the latest on timing for evoxogo and other growth disorders like ISS and SHOX? And then how quickly do you think that you could move 333 here? So would you want to wait for Vox Ogo clinical success here before studying 333 in these indications, or is that something you'd want to do sooner?”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current